Pacira Pharmaceuticals (NSDQ:PCRX) said today that it has signed a deal to acquire Myoscience and its pain relief device for up to $220 million.
Myoscience’s iovera system is designed to safely freeze nerves while protecting surrounding tissue. As part of the deal that is slated to close by early April, Pacira plans to incorporate the iovera system into its non-opioid product portfolio.
Get the full story at our sister site, Drug Delivery Business News.
The post Pacira to acquire Myoscience in $220m deal appeared first on MassDevice.
from MassDevice https://ift.tt/2H703s3
Cap comentari:
Publica un comentari a l'entrada